Drug Shortage Report for M-CLOPIDOGREL
Report ID | 175303 |
Drug Identification Number | 02502283 |
Brand name | M-CLOPIDOGREL |
Common or Proper name | Clopidogrel |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOPIDOGREL |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-11-07 |
Estimated end date | 2023-02-28 |
Actual end date | 2023-03-02 |
Shortage status | Resolved |
Updated date | 2023-03-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-03-06 | French | Compare |
v7 | 2023-03-06 | English | Compare |
v6 | 2023-02-20 | French | Compare |
v5 | 2023-02-20 | English | Compare |
v4 | 2023-01-20 | French | Compare |
v3 | 2023-01-20 | English | Compare |
v2 | 2022-11-18 | French | Compare |
v1 | 2022-11-18 | English | Compare |
Showing 1 to 8 of 8